The vaccine being developed by Oxford and AstraZeneca is widely perceived to be one of the strongest contenders among the dozens of coronavirus vaccines in various stages of testing around the world.
By Pan Pylas, Associated Press
More than 70 rich countries have signed up to a global coronavirus vaccine initiative, which may also allow them to buy more vaccines to stockpile for their own citizens.
By Maria Cheng, Associated Press
Protesters against Africa’s first COVID-19 vaccine trial have burned their face masks as experts note a worrying level of resistance and misinformation around testing on the continent.
By Cara Anna, Associated Press
The head of the Food and Drug Administration says vaccine developers will be expected to study COVID-19 shots in racial minorities, the elderly, pregnant women and those with other health conditions.
By Associated Press
By PBS NewsHour
Pharmaceutical companies and governments around the world are chasing a coronavirus vaccine, fast tracking the usually years-long vaccine development procedure to a few months. ProPublica reporter Caroline Chen joins Hari Sreenivasan to discuss the ambitious timeline and the unpredictability of…
By Lauran Neergaard, Associated Press
A U.S. company says it's on track to begin a huge study next month to prove if its COVID-19 vaccine candidate really works. Moderna Inc. is developing the experimental shot with the National Institutes of Health.
By Maria Cheng, Lauran Neergaard, Associated Press
The British government has hosted a vaccine summit that raised billions of dollars to immunize children in developing countries as expert wrestled with the difficult question of how any potential vaccine against the coronavirus might be distributed globally — and…
By Hope Yen, Calvin Woodward, Associated Press, Marilynn Marchione, AP Chief Medical Writer
So it was this past week when he took very personally a scientific study that should give pause to anyone thinking of following Trump's lead and ingesting a potentially risky drug for the coronavirus. He branded the study's researchers, financed in…
By Marilynn Marchione, AP Chief Medical Writer
An experimental vaccine against the coronavirus showed encouraging results in very early testing, triggering hoped-for immune responses in eight healthy, middle-aged volunteers, its maker announced Monday.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.